Advagene Biopharma Co. Ltd.

This study tested whether an intranasal immunomodulator called AD17002 can help people with poorly controlled moderate to severe eosinophilic asthma. Forty adults self-administered the spray or a placebo twice a week for six weeks. Researchers measured lung function, rescue inhal…

This study tested a nasal spray called AD17002 in 48 adults with dust mite allergies. The goal was to see if it is safe and can reduce allergy symptoms like sneezing and stuffy nose. Participants received either the spray or a placebo, and researchers tracked side effects and sym…